Sort
326,823 grants matching “clinical trial”
Acute HIV-1 Infections Network Core
$2,582,694Myron S Cohen · Duke University · U19 · FY2006 · AI
Acute HIV-1 Infections Network Core
$2,582,694Duke University · U01 · FY2005 · AI
Case Clinical Trials Unit
$2,582,654Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2022 · AI
Collaborative Pediatric Critical Care Research Network
$2,582,551Kevin M Watt · Utah State Higher Education System--University Of Utah · PL1 · FY2025 · HD
Targeting the B Cell Response to Treat Antibody-Mediated Rejection
$2,582,477Stuart Johnston Knechtle · Duke University · U01 · FY2023 · AI
Targeting the B Cell Response to Treat Antibody-Mediated Rejection
$2,582,477Stuart Johnston Knechtle · Duke University · U01 · FY2022 · AI
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,582,338Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,582,338Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA
Winship Cancer Institute Cancer Center Support Grant
$2,582,250Suresh S Ramalingam · Emory University · P30 · FY2022 · CA
Route 66 Endometrial Cancer SPORE
$2,581,832David G Mutch · Washington University · P50 · FY2025 · CA
Wisconsin NCI Community Oncology Research Program (WiNCORP)
$2,581,721Adedayo A Onitilo · Marshfield Clinic, Inc. · UG1 · FY2025 · CA
CPCRA Clinical Trials Unit
$2,581,220Fred M Gordin · George Washington University · U01 · FY2007 · AI
IGF::OT::IGF COORDINATING CENTER CLINICAL TRIALS"OXYTOCIN FOR ALCOHOL USE DISORDER"TASK ORDER NO. 8 - HHSN275201400001I/HHSN27500008TITLE: OXYTOCIN FOR ALCOHOL USE DISORDERPERIOD OF PERFORMANC
$2,580,857Janet Ransom · Fast-Track Drugs And Biologics, Llc · N01 · FY2020 · HD
Development of rationally designed HIV vaccines
$2,580,801Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
SYMPTOM-TARGETED APPROACH TO REHABILITATION FOR CONCUSSION (STAR-C): RANDOMIZED CLINICAL TRIAL OF IN PERSON VS. TELEHEALTH VS WAITLIST CONTROL
$2,580,566The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2024 · Defense Health Agency
Coordination and Statistics for CoQ10 in PD in Phase 3
$2,580,497David Oakes · University Of Rochester · U01 · FY2009 · NS
Center for Clinical and Translational Sciences (CCTS)
$2,580,107David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2014 · TR
Phase II COBRE in Mesenchymal and Neural Regulation of Metabolic Networks
$2,580,000Lucy Liaw · Mainehealth · P20 · FY2024 · GM
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
$2,580,000Daniel M Anderson · Healthpartners Institute · UG1 · FY2016 · CA
Phase II COBRE in Mesenchymal and Neural Regulation of Metabolic Networks
$2,580,000Lucy Liaw · Mainehealth · P20 · FY2025 · GM
Phase II COBRE in Mesenchymal and Neural Regulation of Metabolic Networks
$2,580,000Lucy Liaw · Mainehealth · P20 · FY2023 · GM
Kaiser Permanente NCI National Community Oncology Research Program NCORP
$2,580,000Louis Fehrenbacher · Kaiser Foundation Research Institute · UG1 · FY2015 · CA
The Molecular Drivers and Therapeutic Susceptibilities in Lineage State Transitions of Metastatic Prostate Cancer
$2,579,971Joshua Michael Lang · University Of Wisconsin-Madison · P01 · FY2025 · CA
Protective immunity following dengue virus natural infections and vaccination
$2,579,906Eva Harris · University Of California Berkeley · P01 · FY2020 · AI
Development of an Opioid Sparing Therapeutic to Minimize Opioid Use Disorderand Tolerance in the Treatment of Pain
$2,579,875Malcolm A Meyn · Amalgent Therapeutics, Inc. · R44 · FY2023 · DA